SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Varenhorst Eberhard 1937 )
 

Sökning: WFRF:(Varenhorst Eberhard 1937 ) > Long-term survival ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002827naa a2200301 4500
001oai:DiVA.org:liu-24993
003SwePub
008091007s2000 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-249932 URI
024a https://doi.org/10.1016/S0090-4295(00)00696-82 DOI
040 a (SwePub)liu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Sandblom, Gabrielu Linköpings universitet,Urologi,Hälsouniversitetet4 aut
2451 0a Long-term survival in a swedish population-based cohort of men with prostate cancer
264 1c 2000
338 a print2 rdacarrier
520 a Objectives. To study the long-term survival of patients with prostate cancer, determine the risk factors for prostate cancer death, and investigate the outcome of initially untreated localized prostate cancer and incidentally detected tumors.Methods. The survival of 813 patients in a population-based cohort of patients with prostate cancer in Linköping, Sweden, diagnosed from 1974 to 1986, was analyzed.Results. At 10, 15, and 20 years after diagnosis, the prostate cancer-specific survival rate of men with localized, initially untreated, prostate cancer was 85.0% (95% confidence interval [CI], 79.0% to 91.0%), 80.0% (95% CI, 72.5% to 87.5%), and 62.6% (95% CI, 43.0% to 82.2%). Age 70 years or older, advanced stage, and poor differentiation were risk factors associated with an increased risk of prostate cancer death. At 10 years, the prostate cancer-specific survival rate among men with localized tumors treated by expectancy was 90% (95% CI, 84% to 97%) for grade 1 tumors, 74% (95% CI, 60% to 89%) for grade 2 tumors, and 59% (95% CI, 29% to 90%) for grade 3 tumors. For patients with incidentally detected tumors, the grade of malignancy was a more important risk factor than tumor volume.Conclusions. Patients with localized tumors have a favorable prognosis, even without initial treatment. However, when deciding on therapy, the grade of malignancy should be taken into account, as it has a great influence on survival. We did not see a tendency toward increased mortality when the patients were followed up for longer than 10 years after diagnosis.
653 a MEDICINE
653 a MEDICIN
700a Dufmats, Monika,d 1943-u Linköpings universitet,Onkologi,Hälsouniversitetet4 aut0 (Swepub:liu)mondu07
700a Varenhorst, Eberhard,d 1937-u Linköpings universitet,Urologi,Hälsouniversitetet4 aut0 (Swepub:liu)ebeva05
710a Linköpings universitetb Urologi4 org
773t Urologyg 56:3, s. 442-447q 56:3<442-447x 0090-4295x 1527-9995
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-24993
8564 8u https://doi.org/10.1016/S0090-4295(00)00696-8

Hitta via bibliotek

  • Urology (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Sandblom, Gabrie ...
Dufmats, Monika, ...
Varenhorst, Eber ...
Artiklar i publikationen
Urology
Av lärosätet
Linköpings universitet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy